StockNews.AI
CDNA
StockNews.AI
189 days

CareDx to Report Fourth Quarter and Full Year 2024 Financial Results

1. CareDx to announce Q4 2024 financial results on February 26, 2025. 2. Management conference call scheduled for 1:30 PM PT / 4:30 PM ET. 3. Company focuses on precision medicine for transplant patients.

Earnings
-6%Current Return
VS
-0.35%S&P 500
$24.9102/11 07:34 AM EDTEvent Start
$23.41502/12 02:05 PM EDTLatest Updated
3m saved
Insight
Article

FAQ

Why Neutral?

The scheduled financial announcement typically has no immediate effect on stock price. Past earnings reports have resulted in varied market reactions.

How important is it?

Earnings announcements can influence investor sentiment and stock movement, but expectations can temper their impact.

Why Short Term?

Immediate focus on upcoming earnings might influence trading decisions. Previous earnings reports can create short-term volatility.

Related Companies

CDNA
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced it will report financial results for the fourth quarter and full year 2024 after market close on Wednesday, February 26, 2025. Company management will host a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Individuals interested in listening to the conference call may do so by dialing 1-800-267-6316 for domestic callers or 1-203-518-9783 for international callers. Please reference Conference ID: CareDx. To listen to the webcast, please visit the Events & Presentations section of CareDx’s Investor Relations website at: investors.caredx.com. About CareDx – The Transplant Company CareDx, Inc., headquartered in Brisbane, California, is a leading precision medicine solutions company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the leading provider of genomics-based information for transplant patients. For more information, please visit: www.CareDx.com.

Related News